We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Cooled RFA Relieves Pain Following Knee Replacement

By HospiMedica International staff writers
Posted on 06 Dec 2021
Image: The cooled radiofrequency ablation (C-RFA) procedure (Photo courtesy of Dr. Felix Gonzalez/ RSNA)
Image: The cooled radiofrequency ablation (C-RFA) procedure (Photo courtesy of Dr. Felix Gonzalez/ RSNA)
A new study suggests cooled radiofrequency ablation (C-RFA) offers long-term relief for chronic and debilitating pain after knee replacement surgery.

Researchers at Emory University (Atlanta, GA, USA) conducted a study involving 21 patients who experienced persistent and chronic pain following total knee replacement, without any underlying hardware complications; all of the patients had failed conservative care. For the study, the patients filled out clinically validated questionnaires to assess pain severity, stiffness, functional activities of daily living, and use of pain medication before and after the C-RFA procedure.

Follow-up outcome scores were collected up to one year after the procedure. The questionnaire results showed that the patients experienced, on average, a statistically significant improvement in quality of life, with both pain and stiffness scores improving dramatically. No major complications were seen, and no patients required repeat treatment, surgical revision, or other interventions. The study was presented at the annual meeting of the Radiological Society of North America (RSNA), held during November-December 2021 in Chicago (IL, USA).

“The procedure's long-term relief gives it a major advantage over cortisone injections, which offer on average only about three months of pain relief. It's very encouraging that up to a year out these patients have such significant pain relief and a better quality of life,” said lead author Felix Gonzalez, MD. “With a larger propagating heat wave, you can account for the differences in nerve anatomy from patient to patient because of a larger treatment zone; treating a larger zone increases the effectiveness of the procedure.”

The C-RFA procedure involves insertion of an introducer needle under local anesthesia that targets specific nerve locations around the knee. A probe is then guided through the introducers. The tip of the probe imparts low voltage RFA to the deep sensory nerves around the knee. Water circulating through the system allows for a greater dissipation of heat from the tip of the probe.

Related Links:
Emory University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Hemostatic Agent
HEMOBLAST Bellows
New
Ultrasound Needle Guidance System
SonoSite L25

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more